SZD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Santen Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 9.85 EUR Market Closed

Market Cap: €3.6B

	Santen Pharmaceutical Co Ltd F:SZD	JP
P	Phreesia Inc F:19P	US
	Mynaric AG F:M0YA	DE
A	Axonics Inc F:0I3	US
S	SB Technology Corp XMUN:SB3	JP
D	DMCC Speciality Chemicals Ltd BSE:506405	IN
S	SB Technology Corp DUS:SB3	JP
D	Dongfeng Motor Group Co Ltd XMUN:D4D	CN

Profitability Summary

Santen Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

60% > 59%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

0% > 17%

Healthy Net Margin

13%

Sustainable 3Y Average Net Margin

10%

Net Margin is Increasing

-4% > 13%

Healthy Free Cash Flow Margin

10%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

6% > 10%

Positive ROE

13%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

ROIC is Increasing

2% > 13%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.